Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon in Bionic Pancreas for Exercise in T1D
NCT03217175Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2017
- Primary completion
- Mar 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of glucagon in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Number of Subjects With Plasma Glucose < 60 mg/dl at 1 day. Started Aug 2017; status: terminated.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03217175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03217175.